Date published: 2025-12-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

PC-PLD Inhibitors

Phosphatidylcholine-specific phospholipase D (PC-PLD) is an enzyme that plays a pivotal role in the regulation of cellular processes through its involvement in the hydrolysis of phosphatidylcholine to generate phosphatidic acid and choline. Phosphatidic acid acts as a second messenger in various signaling pathways, thereby influencing a host of cellular functions, including but not limited to membrane trafficking, secretion, cell survival, and proliferation. The expression of PC-PLD is tightly controlled within cells, and dysregulation of this enzyme can lead to alterations in cellular homeostasis. Given its central role in critical cellular mechanisms, the modulation of PC-PLD expression is an area of significant interest, particularly in the context of understanding the molecular basis of its regulation.Research has identified a number of chemical compounds that can potentially influence the expression of PC-PLD. One such compound is Triptolide, a diterpene triepoxide found in the plant Tripterygium wilfordii, which has been shown to downregulate the expression of certain genes at the transcriptional level. Another noteworthy compound is Curcumin, a polyphenol from the spice turmeric, which can decrease the expression of enzymes by inhibiting key signaling pathways such as NF-κB. Compounds like Epigallocatechin gallate (EGCG), found in green tea, can alter gene expression by modifying the epigenetic landscape, leading to changes in chromatin structure and transcription factor accessibility to DNA. Similarly, Resveratrol, a compound found in red wine, grapes, and berries, has been known to downregulate enzyme expression by influencing sirtuin activity, which can alter the acetylation state of histones associated with gene promoters. In the quest to understand the regulation of PC-PLD expression, these compounds, among others, serve as valuable tools in dissecting the complex network of cellular signaling and gene expression control. Their diverse mechanisms of action reflect the intricate nature of cellular regulation and underscore the potential for chemical biology to unlock the secrets of enzyme regulation within the cellular milieu.

SEE ALSO...

Items 11 to 16 of 16 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin can decrease the expression of PC-PLD by specifically inhibiting PI3K, which leads to the downregulation of the AKT signaling pathway and reduced transcriptional activation of the PC-PLD gene.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine can inhibit DNA methylation, potentially causing the demethylation of the PC-PLD gene promoter region and reducing its expression by limiting the binding of methyl-CpG-binding proteins that repress transcription.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib has the ability to inhibit multiple kinases which are responsible for the phosphorylation of transcription factors that control PC-PLD expression, potentially leading to decreased levels of the enzyme.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059 can inhibit MEK1/2, leading to a reduction in ERK/MAPK pathway signaling and a consequent decrease in transcription factors that drive PC-PLD gene expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125, as a JNK inhibitor, could lead to reduced activity of transcription factors that are crucial for the expression of PC-PLD, resulting in lower enzyme levels.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 may inhibit MEK1/2, thereby reducing ERK/MAPK pathway signaling and ultimately leading to decreased expression of the PC-PLD gene by reducing the activation of its transcription factors.